表紙:スライドステイナーの世界市場調査レポート:産業分析、規模、シェア、成長、動向、2023~2030年の予測
市場調査レポート
商品コード
1342911

スライドステイナーの世界市場調査レポート:産業分析、規模、シェア、成長、動向、2023~2030年の予測

Global Slide Stainer Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日: | 発行: Value Market Research | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
スライドステイナーの世界市場調査レポート:産業分析、規模、シェア、成長、動向、2023~2030年の予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

スライドステイナー市場の世界需要は、2022年の7,140,000,000米ドルから2023年~2030年の調査期間においてCAGR 8.92%で2030年には15,410,000,000米ドル近くの市場規模に達すると推定されています。

スライドステイナーは、組織や細胞に染色を施すために使用される化学物質であり、顕微鏡による同定を助け、細胞研究を容易にします。スライドステイナーは、表面吸着、直接染色、媒染剤染色、または間接染色によって染料を標本に広げることにより、準備された細胞診および組織診組織標本の染色を自動化します。自動スライドステイナーで採用されている手順は、直線搬送と回転搬送です。

市場力学:

スライドステイナー製品は、がん、慢性疾患、感染症の増加により大きな需要があります。老人人口の増加、病理組織学におけるAIの利用、がんスクリーニングの急増、がん治療薬の臨床試験の増加。半自動および自動スライド染色システムの迅速、効率的、高スループット機能は、スライドステイナーの市場拡大につながっています。さらに、診断センターの増加、患者数の増加、ヘルスケアインフラの改善もこの市場の成長を牽引しています。さらに、ヘルスケア産業における技術の進歩、自動スライドステインナーの採用増加、診断施設や臨床研究におけるスライドステインの需要増加、検査室の自動化手順の急増などが、スライドステインダーの市場成長を促進する要因となっています。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を対象としています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはスライドステーナーの世界市場における各セグメントを包括的に評価することもできます。スライドステイナー産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析:

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東&アフリカにおけるスライドステイナー市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、すべての主要地域における個々のアプリケーションセグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 スライドステイナー- 産業分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 スライドステーナーの世界市場分析:製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • 試薬(染色希釈液・緩衝液、ブロッキング血清・試薬、固定化試薬・包埋液、プローブ、抗体)
  • 装置(自動・半自動スライドステイナー、手動染色セット)
  • 消耗品および付属品

第7章 スライドステーナーの世界市場分析:技術別

  • 技術別概要
  • 実績データと予測データ
  • 技術別分析
  • ヘマトキシリン・エオジン
  • 免疫組織化学
  • 細胞学
  • 微生物学
  • 特殊染色
  • インサイチュハイブリダイゼーション
  • 血液学

第8章 スライドステーナーの世界市場分析:用途別

  • 概要:用途別
  • 実績データと予測データ
  • 分析:用途別
  • 疾患診断(乳がん、胃がん、リンパ腫、前立腺がん、非小細胞肺がん、その他の疾患)
  • 医療調査

第9章 スライドステーナーの世界市場分析:エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 病院・診断研究所
  • 学術・研究機関
  • 製薬・バイオテクノロジー企業
  • その他のエンドユーザー

第10章 スライドステーナーの世界市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米:セグメント別
    • 北米:国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州:セグメント別
    • 欧州:国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋:セグメント別
    • アジア太平洋:国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ:セグメント別
    • ラテンアメリカ:国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ:セグメント別
    • 中東・アフリカ:国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第11章 スライドステイナーメーカーの競合情勢

  • スライドステイナー市場競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第12章 企業プロファイル

  • 上位企業シェア分析
  • 市場集中度
  • F. Hoffmann-La Roche Ltd.(スイス)
  • Danaher Corporation(米国)
  • PHC Holdings Corporation(日本)
  • Thermo Fisher Scientific Inc.(米国)
  • Merck KGAA(ドイツ)
  • Agilent Technologies Inc.(米国)
  • Abcam Plc.(英国)
  • Becton
  • Dickinson And Company(米国)
  • Siemens Healthineers AG(ドイツ)
  • Biocare Medical LLC(米国)
  • Hardy Diagnostics(米国)
  • General Data Company(米国)
  • ELITechGroup(フランス)
  • Biogenex(米国)
  • Histo-Line Laboratories(イタリア)
  • SLEE medical GmbH(ドイツ)
  • Amos scientific Pty Ltd.(オーストラリア)
  • MEDITE Medical GMBH(ドイツ)
  • Cellpath Ltd(英国)
  • Diapath S.P.A.(イタリア)
  • Bio SB Inc.(米国)
  • Rockland Immunochemicals Inc.(米国)
  • Cell Signaling Technology Inc.(米国)
  • Diagnostic BioSystems Inc.(米国)
  • Dakewe Biotech Co. Ltd.(中国)
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Reagents (Stains Diluents & Buffers, Blocking Sera & Reagents, Mounting Media Fixative Reagents And Embedding Media, Probes, Antibodies) Market Sales by Geography (USD MN)
  • Equipment (Automated & Semi-automated Slide Stainer, Manual Staining Set) Market Sales by Geography (USD MN)
  • Consumables & Accessories Market Sales by Geography (USD MN)
  • Analysis Market by Technology (USD MN)
  • Hematoxylin And Eosin Market Sales by Geography (USD MN)
  • Immunohistochemistry Market Sales by Geography (USD MN)
  • Cytology Market Sales by Geography (USD MN)
  • Microbiology Market Sales by Geography (USD MN)
  • Special Stains Market Sales by Geography (USD MN)
  • In-situ Hybridization Market Sales by Geography (USD MN)
  • Hematology Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Disease Diagnosis (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-small Lung Cancer, Other Diseases) Market Sales by Geography (USD MN)
  • Medical Research Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals & Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Slide Stainer Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Slide Stainer Report
  • Market Research Process
  • Market Research Methodology
  • Global Slide Stainer Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Reagents (Stains Diluents & Buffers, Blocking Sera & Reagents, Mounting Media Fixative Reagents And Embedding Media, Probes, Antibodies) Market Sales by Geography (USD MN)
  • Equipment (Automated & Semi-automated Slide Stainer, Manual Staining Set) Market Sales by Geography (USD MN)
  • Consumables & Accessories Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Hematoxylin And Eosin Market Sales by Geography (USD MN)
  • Immunohistochemistry Market Sales by Geography (USD MN)
  • Cytology Market Sales by Geography (USD MN)
  • Microbiology Market Sales by Geography (USD MN)
  • Special Stains Market Sales by Geography (USD MN)
  • In-situ Hybridization Market Sales by Geography (USD MN)
  • Hematology Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Disease Diagnosis (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-small Lung Cancer, Other Diseases) Market Sales by Geography (USD MN)
  • Medical Research Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals & Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219318

The global demand for Slide Stainer Market is presumed to reach the market size of nearly USD 15.41 BN by 2030 from USD 7.14 BN in 2022 with a CAGR of 8.92% under the study period 2023 - 2030.

Slide stainer is a chemical substance used for imparting stain to tissues and cells, which further assists in microscopic identification and makes cellular research easy. The slide stainer machine automates the staining of prepared cytology and histology tissue specimens by spreading dyes into the specimen by surface adsorption, direct staining, mordant staining, or indirect staining. The procedures employed in the automated slide stainer are linear transport and rotating transport.

MARKET DYNAMICS:

Slide stainer products are in huge demand due to the increasing cases of cancer, chronic illnesses, and infectious diseases. The rising geriatric population, usage of AI in histopathology, surge in cancer screening, and increasing cancer drug trials. The rapid, efficient, and high throughput features of the semi-automated and automated slide staining systems are leading to the market expansion of slide stainers. In addition, the growth in this market will be driven by the increasing number of diagnostic centers, a growing patient base, and improved healthcare infrastructure. Furthermore, technological advancements in the healthcare industry, increasing adoption of automated slide stainers, rising demand for slide stains in diagnostic facilities and clinical research, and a surge in laboratory automation procedures are factors propelling the market growth for slide stainers.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of slide stainer. The growth and trends of slide stainer industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the slide stainer market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Reagents (Stains Diluents & Buffers, Blocking Sera & Reagents, Mounting Media Fixative Reagents And Embedding Media, Probes, Antibodies)
  • Equipment (Automated & Semi-Automated Slide Stainer, Manual Staining Set)
  • Consumables & Accessories

By Technology

  • Hematoxylin And Eosin
  • Immunohistochemistry
  • Cytology
  • Microbiology
  • Special Stains
  • In-Situ Hybridization
  • Hematology

By Application

  • Disease Diagnosis (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Lung Cancer, Other Diseases)
  • Medical Research

By End User

  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Slide Stainer market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the slide stainer market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Thermo Fisher Scientific, Inc. (US), Merck KGAA (Germany), Agilent Technologies, Inc. (US), Abcam Plc. (UK), Becton, Dickinson and Company (US), Siemens Healthineers AG (Germany), Biocare Medical, LLC (US), Hardy Diagnostics (US), General Data Company (US), ELITechGroup (France), Biogenex (US), Histo-Line Laboratories (Italy), SLEE medical GmbH (Germany), Amos scientific Pty Ltd. (Australia), MEDITE Medical GMBH (Germany), Cellpath Ltd (UK), Diapath S.P.A. (Italy), Bio SB, Inc. (US), Rockland Immunochemicals, Inc. (US), Cell Signaling Technology, Inc. (US), Diagnostic BioSystems, Inc. (US), and Dakewe Biotech Co., Ltd. (China). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . SLIDE STAINER - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL SLIDE STAINER MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Reagents (Stains Diluents & Buffers, Blocking Sera & Reagents, Mounting Media Fixative Reagents And Embedding Media, Probes, Antibodies) Historic and Forecast Sales by Regions
  • 6.5 Equipment (Automated & Semi-automated Slide Stainer, Manual Staining Set) Historic and Forecast Sales by Regions
  • 6.6 Consumables & Accessories Historic and Forecast Sales by Regions

7 . GLOBAL SLIDE STAINER MARKET ANALYSIS BY TECHNOLOGY

  • 7.1 Overview by Technology
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Technology
  • 7.4 Hematoxylin And Eosin Historic and Forecast Sales by Regions
  • 7.5 Immunohistochemistry Historic and Forecast Sales by Regions
  • 7.6 Cytology Historic and Forecast Sales by Regions
  • 7.7 Microbiology Historic and Forecast Sales by Regions
  • 7.8 Special Stains Historic and Forecast Sales by Regions
  • 7.9 In-situ Hybridization Historic and Forecast Sales by Regions
  • 7.10. Hematology Historic and Forecast Sales by Regions

8 . GLOBAL SLIDE STAINER MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Disease Diagnosis (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-small Lung Cancer, Other Diseases) Historic and Forecast Sales by Regions
  • 8.5 Medical Research Historic and Forecast Sales by Regions

9 . GLOBAL SLIDE STAINER MARKET ANALYSIS BY END USER

  • 9.1 Overview by End User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End User
  • 9.4 Hospitals & Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 9.5 Academic & Research Institutes Historic and Forecast Sales by Regions
  • 9.6 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
  • 9.7 Other End Users Historic and Forecast Sales by Regions

10 . GLOBAL SLIDE STAINER MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE SLIDE STAINER COMPANIES

  • 11.1. Slide Stainer Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF SLIDE STAINER INDUSTRY

  • 12.1. Top Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. F. Hoffmann-La Roche Ltd. (SwitzerlAnd)
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Danaher Corporation (US)
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. PHC Holdings Corporation (Japan)
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Thermo Fisher Scientific Inc. (US)
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Merck KGAA (Germany)
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Agilent Technologies Inc. (US)
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Abcam Plc. (UK)
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Becton
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Dickinson And Company (US)
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Siemens Healthineers AG (Germany)
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Biocare Medical LLC (US)
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. Hardy Diagnostics (US)
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. General Data Company (US)
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. ELITechGroup (France)
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. Biogenex (US)
    • 12.17.1. Company Overview
    • 12.17.2. Company Revenue
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. Histo-Line Laboratories (Italy)
    • 12.18.1. Company Overview
    • 12.18.2. Company Revenue
    • 12.18.3. Products
    • 12.18.4. Recent Developments
  • 12.19. SLEE medical GmbH (Germany)
    • 12.19.1. Company Overview
    • 12.19.2. Company Revenue
    • 12.19.3. Products
    • 12.19.4. Recent Developments
  • 12.20. Amos scientific Pty Ltd. (Australia)
    • 12.20.1. Company Overview
    • 12.20.2. Company Revenue
    • 12.20.3. Products
    • 12.20.4. Recent Developments
  • 12.21. MEDITE Medical GMBH (Germany)
    • 12.21.1. Company Overview
    • 12.21.2. Company Revenue
    • 12.21.3. Products
    • 12.21.4. Recent Developments
  • 12.22. Cellpath Ltd (UK)
    • 12.22.1. Company Overview
    • 12.22.2. Company Revenue
    • 12.22.3. Products
    • 12.22.4. Recent Developments
  • 12.23. Diapath S.P.A. (Italy)
    • 12.23.1. Company Overview
    • 12.23.2. Company Revenue
    • 12.23.3. Products
    • 12.23.4. Recent Developments
  • 12.24. Bio SB Inc. (US)
    • 12.24.1. Company Overview
    • 12.24.2. Company Revenue
    • 12.24.3. Products
    • 12.24.4. Recent Developments
  • 12.25. Rockland Immunochemicals Inc. (US)
    • 12.25.1. Company Overview
    • 12.25.2. Company Revenue
    • 12.25.3. Products
    • 12.25.4. Recent Developments
  • 12.26. Cell Signaling Technology Inc. (US)
    • 12.26.1. Company Overview
    • 12.26.2. Company Revenue
    • 12.26.3. Products
    • 12.26.4. Recent Developments
  • 12.27. Diagnostic BioSystems Inc. (US)
    • 12.27.1. Company Overview
    • 12.27.2. Company Revenue
    • 12.27.3. Products
    • 12.27.4. Recent Developments
  • 12.28. Dakewe Biotech Co. Ltd. (China)
    • 12.28.1. Company Overview
    • 12.28.2. Company Revenue
    • 12.28.3. Products
    • 12.28.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies